Brief: India's Parmax Pharma Pauses HCQ Production Due To Low Demand
16/07/2020 15:33
July 16 (Reuters) - Parmax Pharma Ltd PARA.BO :
* DUE TO ACUTE DECLINE IN DEMAND OF PRODUCT, CO HAS
TEMPORARILY
STOPPED PRODUCTION OF HYDROXYCHLOROQUINE
Source text for Eikon: ID:nBSE8xtgsZ
Further company coverage: PARA.BO
((bangalore.newsroom@thomsonreuters.com;))